Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rosetta Licenses Greek miRNA Dx Rights to Genekor
July 29, 2010
Rosetta Licenses Greek miRNA Dx Rights to Genekor
The deal covers Rosetta's miRview Meso, miRview Mets, and miRview Squamous tests.
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab
December 2, 2010 / Gene Silencing News
Rosetta Genomics to Sell $1.9M in Securities, Inks miRNA Dx Distribution Deal for China
October 13, 2011 / Gene Silencing News
Rosetta Signs Marketing Deal for Mesothelioma Test with Tort Claims Administration Firm
June 16, 2011 / Gene Silencing News
Rosetta Genomics Unveils Two New Development-Stage Tests
September 9, 2010 / Gene Silencing News
Rosetta Puts Blood-Based Cancer Screen on Back Burner to Refocus on miRNA Diagnostics
December 31, 2009 / Gene Silencing News